ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "COVID-19"

  • Abstract Number: 0799 • ACR Convergence 2022

    Serum Laboratory Parameters of Hemophagocytic Lymphohistiocytosis Syndrome in Patients with Autoimmune Rheumatic Diseases Infected with SARS-CoV-2: A Retrospective Comparative Study

    Omar Alsaed, Samar Al emadi, Karima Becetti, Eman Satti, Hadil Ashour, Yousef Alrimawi, Miral H.Gharib, Mohamad Alkahlout, Rawan Saleh, Basem Awadh and Mohammed Hammoudeh, Hamad Medical Corporation, Doha, Qatar

    Background/Purpose: The serum features of the cytokine storm induced by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are similar to those of hemophagocytic lymphohistiocytosis…
  • Abstract Number: 1194 • ACR Convergence 2022

    Key Self-reported Determinants of COVID-19 Vaccine Acceptance Among Persons with and Without Autoimmune Disease

    Jenny Gong1, Emma Barnboym2, megan O'Mara3, Natalie Gurevich3, Maya Mattar4, Donald Anthony5, Adam Perzynski2 and Nora Singer6, 1Case Western School of Medicine, Cleveland, OH, 2The MetroHealth System, Cleveland, OH, 3Cleveland Veteran Affairs Medical Center, Cleveland, OH, 4Louis Stokes VA Medical Center, Mayfield Heights, OH, 5Case, VA, Metro, Chardon, OH, 6The MetroHealth System at Case Western Reserve University School of Medicine, Cleveland, OH

    Background/Purpose: Patients with autoimmune disease are at increased risk for complications from SARS-CoV-2 infection. We aimed to compare patient perspectives on COVID-19 vaccination among persons…
  • Abstract Number: 1392 • ACR Convergence 2022

    Comparing Data on Rheumatoid Arthritis (RA) Disease Status Using Patient Reported Outcome Measures (PROMS) RAID/RAPID-3/Self-Reported DAS28 in Remote Electronic Monitoring During the COVID-19 Pandemic with Face-To-Face Clinical Evaluation (DAS28-CRP) Performed Pre-Pandemic

    Maria Mirza1, Kaiyang Song1, Madiha Ashraf2, Anushka Soni3, John Jackman3 and Raashid Luqmani1, 1Oxford University Hospital, Oxford, United Kingdom, 2Oxford Universtiy Hospital, Oxford, United Kingdom, 3Oxford University Hospital, Oxford, England, United Kingdom

    Background/Purpose: During the COVID-19 pandemic, asynchronous consultations were introduced due to the significant backlog of patients with Rheumatoid arthritis awaiting clinical review. PROMs including Self-Reported…
  • Abstract Number: 1821 • ACR Convergence 2022

    Colchicine and Other Gout Medications and the Risk of COVID-19 Infection, Hospitalization, and Subsequent Outcomes in People with Gout

    Jasvinder singh1, Timothy Bergquist2, Vithal Madhira3 and Alfred Anzalone4, 1University of Alabama at Birmingham, Birmingham, AL, 2Sage Bionetworks, Seattle, WA, 3Palila Software, L.L.C., Reno, NV, 4University of Nebraska Medical Center, Ohama, NE

    Background/Purpose: To examine whether the use of colchicine and other gout medications is associated with the risk of COVID-19 infection, hospitalization, and subsequent outcomes in…
  • Abstract Number: 2081 • ACR Convergence 2022

    COVID-19 Infections, Morbidity, and Seroreactivity in SLE Patients Following Initial Vaccination Series and Additional Dose Through the New York City Omicron BA.1 Wave

    Amit Saxena1, Alexis Engel2, Brittany Banbury1, Ghadeer Hasan3, Nicola Fraser1, Devyn Zaminski1, Mala Masson4, Rebecca Haberman5, Jose Scher2, Gary Ho6, Jammie Law3, Paula Rackoff1, Chung-E Tseng5, H Michael Belmont1, Robert Clancy1, Jill Buyon7 and Peter Izmirly7, 1NYU School of Medicine, New York, NY, 2New York University School of Medicine, New York, NY, 3NYU Langone, New York, NY, 4NYU Langone Medical Center- Division of Rheumatology, New York, NY, 5NYU Langone Health, New York, NY, 6New York University Grossman School of Medicine, VA New York Harbor Health Care System, Brooklyn, NY, 7NYU Grossman School of Medicine, New York, NY

    Background/Purpose: Patients with systemic lupus erythematosus (SLE) are at high risk for severe disease from COVID-19 and decreased vaccine efficacy, due to inherent immune perturbations…
  • Abstract Number: 0108 • ACR Convergence 2022

    Study of the Level of Antibody Response to COVID-19 Vaccine in a Minority Population with Rheumatological Disorders

    Tanushree Bhatt, Snigdha Gadireddy, Pravash Budhathoki and Giovanni Franchin, Bronxcare Health System, Bronx, NY

    Background/Purpose: Multiple studies have shown reduced immunogenicity of mRNA covid vaccines in patients with rheumatological disease. The waning antibody levels in this population group, whether…
  • Abstract Number: 0440 • ACR Convergence 2022

    COVID-19 in Patients with ANCA Associated Vasculitis – Single Center Experience

    Alojzija Hocevar1, Matija Tomšič2 and Ziga Rotar1, 1University Medical Centre Ljubljana, Ljubljana, Slovenia, 2UMC Ljubljana, LJUBLJANA, Slovenia

    Background/Purpose: In patients with ANCA associated vasculitis (AAV) a higher mortality rate due to COVID-19 has been observed compared to general population. We aimed to…
  • Abstract Number: 0748 • ACR Convergence 2022

    Mapping Long COVID-19 Patient Journeys for Rheumatic Disease Patients

    Yomei Shaw1, Beth Wallace2, Hallie Chabrier3, Charlotte Cochrane3, Christina Kim3, Katherine Taylor3, Armaan Patel3, Nima Keyvan4, Vinayak Swaroop3, Nina Nguyen3, Sara Hustek5, Meriah Moore4, Andrew Admon4 and Kaleb Michaud6, 1FORWARD, The National Databank for Rheumatic Diseases, Santa Fe, NM, 2Michigan Medicine, VA Ann Arbor Healthcare System, Ann Arbor, MI, 3University of Michigan Division of Rheumatology, Ann Arbor, MI, 4University of Michigan, Ann Arbor, MI, 5University of Michigan Division of Rheumatology, Mount Clemens, MI, 6University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: One-third of individuals who contract COVID-19 develop 'long COVID' symptoms that persist after their initial illness. Long COVID can cause fatigue, chronic pain, and…
  • Abstract Number: 0784 • ACR Convergence 2022

    Breakthrough SARS-CoV-2 Infections in Immune Mediated Disease Patients Undergoing B Cell Depleting Therapy: A Retrospective Cohort Analysis

    Cassandra Calabrese1, Elizabeth Kirchner2, M. Elaine Husni3, Brandon Moss2, Anthony Fernandez2, Yuxuan Jin3 and Leonard Calabrese3, 1Cleveland Clinic Foundation, Cleveland Heights, OH, 2Cleveland Clinic Foundation, Cleveland, OH, 3Cleveland Clinic, Cleveland, OH

    Background/Purpose: Immunocompromised patients with immune mediated inflammatory diseases (IMIDs) undergoing therapy with B cell depleting agents (BCDT) are among the most vulnerable to severe COVID-19…
  • Abstract Number: 0817 • ACR Convergence 2022

    Predictive Severity Factors of COVID-19 in Patients with Rheumatic Immune Mediated Diseases

    David Martínez-López1, Ivan Ferraz Amaro2, Diana Prieto-Peña3, Fabricio Benavides Villanueva1, Cristina Corrales1, Lara Sánchez-Bilbao1, Alba Herrero-Morant4, Carmen Alvarez Reguera1, martín Trigueros-Vazquez1, Reinhard Wallmann5, Miguel Ángel González-Gay6 and Ricardo Blanco7, 1Hospital Universitario Marqués de Valdecilla, Santander, Spain, 2Division of Rheumatology. Hospital Universitario de Canarias. Spain., Santa Cruz de Tenerife, Spain, 3Research Group on Genetic Epidemiology and Atherosclerosis in Systemic Diseases and in Metabolic Bone Diseases of the Musculoskeletal System, IDIVAL; and Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, Santander, Spain, 4Hospital Universitario Marqués de Valdecilla, Ontinyent, Spain, 5Servicio Cántabro de Salud, Santander, Spain, 6Department of Medicine and Psychiatry, Universidad de Cantabria; Rheumatology Division, Hospital Universitario Marqués de Valdecilla; Research group on genetic epidemiology and atherosclerosis in systemic diseases and in metabolic diseases of the musculoskeletal system, IDIVAL, Santander, Spain. Cardiovascular Pathophysiology and Genomics Research Unit, School of Physiology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa, 7Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain

    Background/Purpose: COVID-19 has become a common disease in patients with rheumatic immune-mediated diseases (R-IMID). A risk stratification of the patients at COVID-19 onset is important…
  • Abstract Number: 1197 • ACR Convergence 2022

    Folic Acid and Methotrexate Use and Their Association with COVID-19 Diagnosis and Mortality: An Analysis from the UK Biobank

    Ruth Topless1, Ralph Green2, Sarah L Morgan3, Philip Robinson4, Tony Merriman1 and Angelo Gaffo3, 1University of Otago, Dunedin, New Zealand, 2Departments of Pathology and Medicine, University of California Davis at Sacramento, Sacramento, CA, 3University of Alabama at Birmingham, Birmingham, AL, 4School of Clinical Medicine, University of Queensland, Brisbane, Australia

    Background/Purpose: Folate metabolism is implicated in SARS-CoV-2 infectivity. The current study seeks to determine if methotrexate (an antifolate) or folic acid prescription were associated with…
  • Abstract Number: 1489 • ACR Convergence 2022

    Incidence of Herpes Zoster Events After the Three Doses of the BNT162b2 mRNA Vaccine in Patients with Spondyloarthritis

    Devy Zisman1, Noa Hayat1, Amir Haddad2, Joy Feld3, Tal Gazitt1, Idit Lavi1, Ilan feldhamer4, ARNON DOV COHEN4 and Walid Saliba1, 1Carmel Medical Center, Haifa, Israel, 2Carmel Medical Centre, Haifa, Israel, 3Carmel and Zvulun Medical Centre, Haifa, Israel, 4Clalit Health Services, Tel Aviv, Israel

    Background/Purpose: The importance and efficacy of anti COVID-19 vaccine in coping with the pandemic are well established, but inconsistencies remain in the data regarding side…
  • Abstract Number: 1857 • ACR Convergence 2022

    Increasing Proportion of MDA-5 Associated Conditions in a Tertiary Myositis Centre Following Onset of the Covid-19 Pandemic

    Jennifer Hannah1, Saadia Sasha Ali1, Sloni Arora1, John Cazabon1, James Galloway1 and Patrick Gordon2, 1King's College London, London, United Kingdom, 2King’s College Hospital NHS Foundation Trust, London, United Kingdom

    Background/Purpose: Anti-MDA5 dermatomyositis is a clinical subtype of DM that is strongly associated with a rapidly progressive phenotype of interstitial lung disease resulting in a…
  • Abstract Number: 2084 • ACR Convergence 2022

    COVID-19 Vaccination in Autoimmune Diseases Study: Vaccine Safety in Systemic Lupus Erythematosus

    Naveen R1, Elena Nikiphorou2, Mrudula Joshi3, Parikshit Sen4, Vishwesh Agarwal5, Sinan Kardes6, James B. Lilleker7, Hector Chinoy8, Oliver Distler9, Minchul Kim10, Ai Lyn Tan11, Samuel Shinjo12, Babur Salim13, Tamer A Gheita14, Nelly Ziade15, Tsvetelina Velikova16, Tulika Chatterjee10, Arvind Nune17, Marcin Milchert18, Abraham Edgar Gracia-Ramos19, Albert Selva O’Callaghan20, Miguel Angel Saavedra Salinas21, Lorenzo Cavagna22, Masataka Kuwana23, Johannes Knitza24, Jessica Day25, Ashima Makol26, Rohit Aggarwal27, Vikas Agarwal1, Latika Gupta28, Lisa S Traboco29, CoVAD Study Group30 and Ioannis Parodis31, 1Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, 2Leiden University Medical Center & King's College London, London, United Kingdom, 3Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India, 4Maulana Azad Medical College, New Delhi, India, 5Mahatma Gandhi Missions Medical College, Lucknow, India, 6Istanbul University, Istanbul, Turkey, 7The University of Manchester, Manchester, United Kingdom, 8The University of Manchester, Sale, United Kingdom, 9Department of Rheumatology, University Hospital Zurich, University of Zurich, Zürich, Switzerland, 10University of Illinois College of Medicine Peoria, Peoria, IL, 11University of Leeds, Leeds, United Kingdom, 12Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil, 13Fauji foundation hospital Rawalpindi, Rawalpindi, Pakistan, 14Rheumatology Department, Faculty of Medicine, Cairo University, Cairo, Egypt, 15Saint-Joseph University, Beirut, Lebanon, 16Sofia University St. Kliment Ohridski, Sofia, Bulgaria, 17Southport and Ormskirk Hospital NHS Trust, Southport, United Kingdom, 18Pomeranian Medical University in Szczecin, Szczecin, Poland, 19Instituto Mexicano del Seguro Social, Ciudad de México, Mexico, 20Hospital Universitari Vall d'Hebron, Barcelona, Spain, 21IMSS, Ciudad de México, Mexico, 22Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy, Pavia, Italy, 23Nippon Medical School Graduate School of Medicine, Tokyo, Japan, 24Department of Internal Medicine 3 – Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg and Universitätsklinikum Erlangen, 91054 Erlangen, Germany; Deutsches Zentrum Immuntherapie, Friedrich-Alexander-UniversityErlangen-Nürnberg and Universitätsklinikum Erlangen, Erlangen, Germany, 25Walter and Eliza Hall Institute, Melbourne, Australia, 26Mayo Clinic, Rochester, MN, Rochester, MN, 27Division of Rheumatology and Clinical Immunology, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 28Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom, 29St Luke's Medical Center - BGC, Manila, Philippines, 30CoVAD study group, Wolwehampton, United Kingdom, 31Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: The COVID-19 vaccination in autoimmune diseases (COVAD) study is a large-scale real-world survey on COVID-19 vaccine safety in autoimmune rheumatic diseases (AIRDs), including systemic…
  • Abstract Number: 0134 • ACR Convergence 2022

    Combination Treatment with Baricitinib and Pulse Steroids in Severe COVID19: A

    Francesco Ferro1, Elena Elefante2, Italiano Nazzareno2, Gaetano La Rocca3, Davide Schilirò2, Michele Moretti2, Roberto Mozzo4, De Simone Luigi4, Chiara Baldini5 and Marta Mosca2, 1Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Pisa, Italy, 2University of Pisa, Pisa, Italy, 3University of Pisa, Rheumatology Unit, Palermo, Palermo, Italy, 4Anesthesiology & Intensive Care Unit/Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 5University of Pisa, Pisa, Pisa, Italy

    Background/Purpose: Growing evidence from RCTs and real-life experiences has highlighted important similarities between severe COVID19 and rapidly progressive interstitial lung diseases (RP-ILD) occurring in connective…
  • « Previous Page
  • 1
  • …
  • 13
  • 14
  • 15
  • 16
  • 17
  • …
  • 38
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology